Alyeska Investment Group’s CONMED CNMD Stock Holding History

Alyeska Investment Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,700	Closed	-$482K	–	482
2020 Q2	$482K	Buy	+6,700	New	+$466K	0.01%	438

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Alyeska Investment Group's CNMD Position: Q3 2020 in Review

Alyeska Investment Group sold out of CONMED (CNMD) in Q3 2020, closing a stake of 6,700 shares — an estimated $482K sold.

Alyeska Investment Group first reported a position in CNMD in Q2 2020 and held it in 1 quarter. The position peaked at $482K in Q2 2020. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

Alyeska Investment Group reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
Alyeska Investment Group sold 6,700 CONMED shares in Q3 2020, an estimated $482K.
Alyeska Investment Group first reported a position in CONMED in Q2 2020 and held it in 1 quarter.
Alyeska Investment Group's CONMED position peaked at $482K in Q2 2020.
240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.